Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
The New England Journal of Medicine
|
January 7, 2026
Azithromycin for Infants in Mali to Reduce Mortality. Reply
Fadima Cheick Haidara, Laura Adubra, Per Ashorn
Current Developments in Nutrition
|
March 23, 2019
The Minimum Dietary Diversity for Women of Reproductive Age (MDD-W) Indicator Is Related to Household Food Insecurity and Farm Production Diversity: Evidence from Rural Mali
Laura Adubra, Mathilde Savy, Sonia Fortin, et al.
The American Journal of Clinical Nutrition
|
September 29, 2019
Conditional cash transfer and/or lipid-based nutrient supplement targeting the first 1000 d of life increased attendance at preventive care services but did not improve linear growth in young children in rural Mali: results of a cluster-randomized controlled trial
Laura Adubra, Agnes Le Port, Yves Kameli, et al.
Maternal & Child Nutrition
|
August 1, 2022
Association between prenatal provision of lipid-based nutrient supplements and caesarean delivery: Findings from a randomised controlled trial in Malawi
Meeri Salenius, Juha Pyykkö, Ulla Ashorn, et al.
Plos Medicine
|
November 17, 2020
Evaluation of an unconditional cash transfer program targeting children's first-1,000-days linear growth in rural Togo: A cluster-randomized controlled trial
Justine Briaux, Yves Martin-Prevel, Sophie Carles, et al.
JAMA Network Open
|
June 10, 2026
Infant Growth After Mass Administration of Azithromycin: Secondary Outcomes of a Cluster Randomized Clinical Trial
Laura Adubra, Juho Luoma, Yue-Mei Fan, et al.
BMJ Open
|
June 16, 2022
SARS-CoV-2 infection and antibody seroprevalence in routine surveillance patients, healthcare workers and general population in Kita region, Mali: an observational study 2020-2021
Dagmar Alber, Fadima Cheick Haidara, Juho Luoma, et al.
Trials
|
January 3, 2023
Testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1-11-month-old infants in Mali (LAKANA): study protocol for a cluster-randomized, placebo-controlled, double-blinded, parallel-group, three-arm clinical trial
Laura Adubra, Dagmar Alber, Per Ashorn, et al.
Maternal & Child Nutrition
|
September 16, 2022
Association between asymptomatic infections and linear growth in 18-24-month-old Malawian children
Juho Luoma, Laura Adubra, Per Ashorn, et al.
Trials
|
November 16, 2023
Statistical analysis plan for the LAKANA trial: a cluster-randomized, placebo-controlled, double-blinded, parallel group, three-arm clinical trial testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1-11-month-old infants in Mali
Juho Luoma, Laura Adubra, Dagmar Alber, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
The New England Journal of Medicine
|
January 7, 2026
Azithromycin for Infants in Mali to Reduce Mortality. Reply
Fadima Cheick Haidara, Laura Adubra, Per Ashorn
Current Developments in Nutrition
|
March 23, 2019
The Minimum Dietary Diversity for Women of Reproductive Age (MDD-W) Indicator Is Related to Household Food Insecurity and Farm Production Diversity: Evidence from Rural Mali
Laura Adubra, Mathilde Savy, Sonia Fortin, et al.
The American Journal of Clinical Nutrition
|
September 29, 2019
Conditional cash transfer and/or lipid-based nutrient supplement targeting the first 1000 d of life increased attendance at preventive care services but did not improve linear growth in young children in rural Mali: results of a cluster-randomized controlled trial
Laura Adubra, Agnes Le Port, Yves Kameli, et al.
Maternal & Child Nutrition
|
August 1, 2022
Association between prenatal provision of lipid-based nutrient supplements and caesarean delivery: Findings from a randomised controlled trial in Malawi
Meeri Salenius, Juha Pyykkö, Ulla Ashorn, et al.
Plos Medicine
|
November 17, 2020
Evaluation of an unconditional cash transfer program targeting children's first-1,000-days linear growth in rural Togo: A cluster-randomized controlled trial
Justine Briaux, Yves Martin-Prevel, Sophie Carles, et al.
JAMA Network Open
|
June 10, 2026
Infant Growth After Mass Administration of Azithromycin: Secondary Outcomes of a Cluster Randomized Clinical Trial
Laura Adubra, Juho Luoma, Yue-Mei Fan, et al.
BMJ Open
|
June 16, 2022
SARS-CoV-2 infection and antibody seroprevalence in routine surveillance patients, healthcare workers and general population in Kita region, Mali: an observational study 2020-2021
Dagmar Alber, Fadima Cheick Haidara, Juho Luoma, et al.
Trials
|
January 3, 2023
Testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1-11-month-old infants in Mali (LAKANA): study protocol for a cluster-randomized, placebo-controlled, double-blinded, parallel-group, three-arm clinical trial
Laura Adubra, Dagmar Alber, Per Ashorn, et al.
Maternal & Child Nutrition
|
September 16, 2022
Association between asymptomatic infections and linear growth in 18-24-month-old Malawian children
Juho Luoma, Laura Adubra, Per Ashorn, et al.
Trials
|
November 16, 2023
Statistical analysis plan for the LAKANA trial: a cluster-randomized, placebo-controlled, double-blinded, parallel group, three-arm clinical trial testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1-11-month-old infants in Mali
Juho Luoma, Laura Adubra, Dagmar Alber, et al.
Page
of 2